Ventas (VTR) Set to Announce Earnings on Friday

Ventas (NYSE:VTR) will be announcing its earnings results before the market opens on Friday, April 26th. Analysts expect the company to announce earnings of $0.96 per share for the quarter. Ventas has set its FY 2019 guidance at $3.75-3.85 EPS and its FY19 guidance at $3.75-3.85 EPS.Investors interested in registering for the company’s conference call can do so using this link.

Ventas (NYSE:VTR) last released its quarterly earnings data on Friday, February 8th. The real estate investment trust reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.01. The firm had revenue of $923.26 million during the quarter, compared to analyst estimates of $913.92 million. Ventas had a return on equity of 3.54% and a net margin of 10.93%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.03 earnings per share. On average, analysts expect Ventas to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

NYSE:VTR opened at $59.52 on Thursday. The company has a market cap of $21.05 billion, a PE ratio of 14.62, a P/E/G ratio of 8.15 and a beta of 0.32. Ventas has a fifty-two week low of $46.55 and a fifty-two week high of $65.70. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 1.04.

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Monday, April 1st were paid a dividend of $0.7925 per share. This represents a $3.17 dividend on an annualized basis and a dividend yield of 5.33%. The ex-dividend date was Friday, March 29th. Ventas’s dividend payout ratio (DPR) is presently 77.89%.

A number of analysts have recently weighed in on VTR shares. Zacks Investment Research lowered Ventas from a “hold” rating to a “sell” rating in a research note on Monday, December 31st. ValuEngine lowered Ventas from a “buy” rating to a “hold” rating in a research note on Tuesday, April 16th. BMO Capital Markets raised their price target on Ventas from $62.00 to $64.00 and gave the stock a “market perform” rating in a research note on Monday, March 4th. Deutsche Bank raised their price target on Ventas from $54.00 to $57.00 and gave the stock a “hold” rating in a research note on Friday, March 29th. Finally, Morgan Stanley initiated coverage on Ventas in a research note on Thursday, March 28th. They issued an “equal weight” rating and a $61.00 price target for the company. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $59.33.

In related news, Chairman Debra A. Cafaro sold 68,084 shares of the firm’s stock in a transaction on Wednesday, February 13th. The stock was sold at an average price of $64.09, for a total value of $4,363,503.56. Following the completion of the sale, the chairman now owns 805,835 shares of the company’s stock, valued at $51,645,965.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Robert F. Probst sold 10,000 shares of the firm’s stock in a transaction on Friday, February 15th. The stock was sold at an average price of $65.01, for a total value of $650,100.00. The disclosure for this sale can be found here. Insiders sold 111,577 shares of company stock valued at $7,149,673 in the last ninety days. 1.40% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: This piece was posted by Dakota Financial News and is owned by of Dakota Financial News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at

About Ventas

Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.

Read More: Intrinsic Value

Earnings History for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with's FREE daily email newsletter.